HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proliferative lupus nephritis in a patient with systemic lupus erythematosus and longstanding secondary amyloid nephropathy.

Abstract
Secondary amyloidosis is an unusual complication of systemic lupus erythematosus (SLE). We report the case of a 60-year-old woman with SLE and secondary amyloidosis who developed class III proliferative lupus nephritis 13 years after the onset of amyloid nephropathy. The patient was treated with mycophenolate mofetil (1.5 g/day) with a significant improvement in proteinuria.
AuthorsJose A Gómez-Puerta, Ricard Cervera, Concepción Moll, Manel Solé, Antonio Collado, Raimon Sanmartí
JournalClinical rheumatology (Clin Rheumatol) Vol. 28 Issue 1 Pg. 95-7 (Jan 2009) ISSN: 1434-9949 [Electronic] Germany
PMID18941705 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Amyloid
  • Anti-Inflammatory Agents, Non-Steroidal
  • Mycophenolic Acid
Topics
  • Amyloid (metabolism)
  • Amyloidosis (complications, drug therapy, pathology)
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Female
  • Humans
  • Kidney (metabolism, pathology)
  • Kidney Glomerulus (metabolism, pathology)
  • Lupus Nephritis (complications, drug therapy, pathology)
  • Middle Aged
  • Mycophenolic Acid (analogs & derivatives, therapeutic use)
  • Proteinuria (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: